#favorable — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #favorable, aggregated by home.social.
-
https://www.europesays.com/ch/124028/ Novartis remibrutinib, a high-efficacy oral BTK inhibitor, significantly reduces relapse rates and shows favorable safety profile in Phase III RMS trials #a #and #BTK #favorable #HighEfficacy #III #in #inhibitor #Novartis #oral #Phase #profile #rates; #reduces #relapse #remibrutinib #RMS #Safety #shows #significantly #Trials